Q2 2020

Source filing unavailable

Q2 2020 · —

Revenue—

Net Income

-$304.71K

N/M vs Q2 2019

EPS Diluted

$0.00

N/M vs Q2 2019

Gross Profit$131,469—

Operating Income-$304,465N/M

Same quarter

Metric	Q2 2020	Q2 2019	Q2 2018	Q2 2017
Revenue	—	$0.00	$0.00	$0.00
Net Income	-$304.71K	-$35.00K	-$37.00K	-$43.00K
EPS Diluted	$0.00	-$0.03	-$0.03	-$0.03

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Yubo International Biotech Ltd · CIK 895464 · Engraved from SEC EDGAR